Augmented trabeculectomy in paediatric glaucoma

R Ehrlich1, M Snir, M Lusky

  • 1Department of Ophthalmology, Rabin Medical Center, Beilinson Campus, Petah Tiqva 49 100, Israel. ehrlichy@netvision.net.il

Insights

Augmented trabeculectomy using mitomycin C and 5-fluorouracil effectively lowered intraocular pressure in pediatric glaucoma patients. This surgical approach shows promise as a primary treatment for selected young individuals with glaucoma.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Pediatric Glaucoma Management

Background:

  • Pediatric glaucoma presents unique management challenges.
  • Trabeculectomy is a common glaucoma surgery, but augmentation may improve outcomes.
  • Mitomycin C and 5-fluorouracil are antimetabolites used to enhance surgical success.

Purpose of the Study:

  • To evaluate the efficacy and safety of trabeculectomy augmented with mitomycin C and 5-fluorouracil in treating pediatric glaucoma.
  • To assess the impact on intraocular pressure, visual acuity, and optic nerve status.
  • To determine the long-term success rates and complication profile of this combined surgical approach.

Main Methods:

  • A retrospective, interventional case series was conducted.
  • Seventeen children (29 eyes) with primary or secondary glaucoma underwent augmented trabeculectomy.
  • Data collected included preoperative/postoperative intraocular pressure, visual acuity, optic disc status, and complications.

Main Results:

  • Intraocular pressure significantly decreased from a mean of 33.1 mmHg to 17.1 mmHg (p <0.0001).
  • Successful intraocular pressure control (<20 mmHg) was achieved in 75.8% of eyes, with a 3-year success rate of 86%.
  • Complications were infrequent, including retinal detachment, choroidal detachment, and blebitis in isolated cases.

Conclusions:

  • Augmented trabeculectomy with mitomycin C and 5-fluorouracil is a viable primary surgical option for select pediatric glaucoma patients.
  • The procedure demonstrated significant intraocular pressure reduction and acceptable safety profile.
  • Further research may refine patient selection for optimal outcomes.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...